PANDEMIC PULSE

Facebook
Twitter
LinkedIn
Print

FDA Expands Vaccine Booster Eligibility to 16 Years and Older

On December 9, 2021, the U.S. Food and Drug Administration (FDA) amended the Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine (marketed as Comirnaty). The amended EUA now allows individuals 16 and 17 years of age to receive a booster dose of the Pfizer-BioNTech vaccine at least six months after completion of the primary vaccination series with the same vaccine. Allowing these individuals to receive a booster dose heading into the holiday season is a welcome development as researchers race to study the new Omicron variant, which has demonstrated antibody resistance. Are you planning on meeting with friends and family during the holidays? Pandemic Patients recommends consulting with your health care provider to discuss getting vaccinated as soon as possible. 

Unsure if you’re eligible to receive a COVID-19 vaccine or booster? Check out our COVID-19 Vaccine Eligibility Guide.

FDA Grants EUA to Novavax COVID-19 Vaccine

On July 13, 2022, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) to Novavax’s COVID-19 vaccine. The FDA’s authorization of this vaccine provides an additional option for individuals who wish to get vaccinated against COVID-19.

Continue Reading...

FDA Authorizes Pfizer and Moderna COVID-19 Vaccines for Children

On June 17, 2022, the U.S. Food and Drug Administration (FDA) amended the Emergency Use Authorizations (EUA) for the Pfizer and Moderna vaccines (marketed as Comirnaty and Spikevax) to allow children as young as six months to get vaccinated against COVID-19. In making this decision, the FDA concluded that the vaccines are safe and effective for use in this population and that the benefits of vaccination outweigh the potential risks.

Continue Reading...

FDA Authorizes First Vaccine Booster for Children 5-11

On May 17, 2022, the U.S. Food and Drug Administration (FDA) amended the Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine (marketed as Comirnaty) to authorize the use of a single booster dose for children between the ages of five and eleven. The FDA authorized the administration of this booster at least five months after the completion of the primary vaccination series with the same vaccine.

Continue Reading...

DONATE NOW to support Pandemic Patients

Bivalent COVID-19 vaccine boosters are now available.

Get your booster today!

"Pandemic Patients relies on donations from the public to operate. With a tax-deductible gift, you can partner with us to help support patients and survivors of COVID-19. Can you make a $10 donation to Pandemic Patients today?"